Children’s Hospital of Wisconsin opened its MACC Fund Center clinical and Northwestern Mutual Day Hospital

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

CHILDREN’S HOSPITAL OF WISCONSIN opened its MACC Fund Center clinic and Northwestern Mutual Day Hospital.

“Children’s Hospital of Wisconsin is grateful for its long standing partnership with the MACC Fund, an organization exceptionally dedicated to children with cancer and blood disorders,” said Peggy Troy, CEO of the Children’s Hospital of Wisconsin. “Through the support of the MACC Fund and Northwestern Mutual, we are able to continue our mission to advance diagnosis and treatments, provide excellence in clinical care, expand training and research efforts, and improve access and outcomes.”

The new care areas on the fifth floor of Children’s Hospital are co-located with the MACC Fund Center inpatient unit and critical care unit. Designed with the help of 10 former MACC Fund Center patients and their families, the renovation features a 10,384-square-foot clinic with the latest technology for improved care delivery, 18 exam rooms and a neuropsychiatric testing suite.

The 10,329-square-foot day hospital includes an activities center, 14 private infusion suites, and a specialized chemotherapy pharmacy.

“We are proud to introduce the Northwestern Mutual Day Hospital, which will enable the doctors, nurses and staff to provide a best-in-class experience to the patients and their families, integrating technology and support services,” said John Kordsmeier, president of the Northwestern Mutual Foundation. “When a child receives a cancer diagnosis, the family does as well. We want to help ensure that when a family is undergoing treatment, they have a family-friendly environment that allows kids to be kids.”

Since the MACC Fund Center program began in 1980: more than 5,000 children have received care through the Oncology Program; more than 1,000 children have received blood and marrow transplants; and 300 children are actively managed for sickle cell disease annually, and 250 new patients are treated for other blood disorders.

YOU MAY BE INTERESTED IN

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.
When it comes to fighting cancer today, collaboration is key. At a time when funding is uncertain, yet innovative breakthroughs are accelerating every day, it’s more important than ever for oncologists, scientists, academic researchers, and community physicians, to come together to share knowledge and gain insights about the forefront of cancer research.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login